Volume 14 Issue 4
Jul.  2023
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2023  >  14(4): 553-561
Zheng Shanshan, Huang Jie, Zheng Zhe, et al. Analysis of effect of preoperative renal insufficiency on clinical prognosis of heart transplant recipients[J]. ORGAN TRANSPLANTATION, 2023, 14(4): 553-561. doi: 10.3969/j.issn.1674-7445.2023.04.012
Citation: Zheng Shanshan, Huang Jie, Zheng Zhe, et al. Analysis of effect of preoperative renal insufficiency on clinical prognosis of heart transplant recipients[J]. ORGAN TRANSPLANTATION, 2023, 14(4): 553-561. doi: 10.3969/j.issn.1674-7445.2023.04.012
shu

Analysis of effect of preoperative renal insufficiency on clinical prognosis of heart transplant recipients

doi: 10.3969/j.issn.1674-7445.2023.04.012

  • Department of Cardiac Surgery, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing 100037, China

More Information
  • Corresponding author: Liu Sheng, Email: liusheng@fuwai.com
  • Received Date: 2023-03-09
    Available Online: 2023-07-13
  • Publish Date: 2023-07-15
    Abstract
  •   Objective  To evaluate the effect of renal insufficiency before heart transplantation on perioperative death, complications and long-term survival, and to compare the differences between preoperative serum creatinine (Scr) and estimated glomerular filtration rate (eGFR) in preoperative risk assessment.  Methods  Clinical data of 1 095 heart transplant recipients were retrospectively analyzed. According to preoperative Scr level, all recipients were divided into the Scr < 133 μmol/L(n=980), Scr 133-176 μmol/L (n=83) and Scr≥177 μmol/L groups (n=32). According to preoperative eGFR, all recipients were divided into eGFR≥90 mL/(min·1.73m2) (n=436), eGFR 60-89 mL/(min·1.73m2) (n=418) and eGFR < 60 mL/(min·1.73m2) groups (n=241). Clinical prognosis of postoperative renal function, perioperative and long-term outcomes of recipients were compared among different groups. The effect of eGFR and Scr level on renal function injury and long-term survival after heart transplantation was assessed.  Results  With the increase of preoperative Scr level, the proportion of recipients undergoing postoperative continuous renal replacement therapy (CRRT) was increased, the proportion of recipients receiving postoperative mechanical circulatory support was elevated, the incidence of postoperative complications was increased, the duration of mechanical ventilation and intensive care unit(ICU) stay was prolonged, and the in-hospital fatality was increased. The differences among three groups were statistically significant (all P < 0.05). With the decrease of preoperative eGFR, the proportion of recipients receiving postoperative CRRT was increased, the proportion of recipients using postoperative intra-aortic balloon pump (IABP) was elevated, the duration of mechanical ventilation and ICU stay was prolonged, and the in-hospital fatality was increased. The differences among three groups were statistically significant (all P < 0.05). Scr≥177 μmol/L was an independent risk factor for postoperative death [adjusted hazard ratio (HR) 3.64, 95% confidence interval (CI) 1.89-6.99, P < 0.01]. Among different groups classified by Scr and eGFR, the cumulative incidence rate of postoperative renal function injury and long-term survival rate were statistically significant among three groups (all P < 0.05). In patients with preoperative Scr < 133 μmol/L, the cumulative incidence rate of postoperative long-term renal function injury was significantly increased with the decrease of preoperative eGFR (P < 0.01). There was no significant difference in postoperative long-term survival rate among patients stratified by different eGFR (P > 0.05).  Conclusions  Renal insufficiency before heart transplantation is associated with poor perioperative and long-term prognosis. Preoperative Scr and eGFR are the independent risk factors for postoperative renal function injury. Scr yields low sensitivity in the assessment of preoperative renal function, whereas it has high accuracy in predicting perioperative death risk. And eGFR is a more sensitive parameter to evaluate preoperative renal function, which may identify early-stage renal functional abnormality and take effective measures during early stage to reduce adverse effect on prognosis.

     

    • FullText(HTML)
  • loading
    • References(35)
  • [1]
    郑珊珊, 刘盛, 唐汉韡, 等. 危重状态病人心脏移植的早期结果: 阜外医院单中心经验[J]. 器官移植, 2021, 12(4): 450-457. DOI: 10.3969/j.issn.1674-7445.2021.04.012.

    ZHENG SS, LIU S, TANG HW, et al. Early outcomes of heart transplantation in critical patients: single center experience of Fuwai Hospital[J]. Organ Transplant, 2021, 12(4): 450-457. DOI: 10.3969/j.issn.1674-7445.2021.04.012.
    [2]
    LALA A, ROWLAND JC, FERKET BS, et al. Strategies of wait-listing for heart transplant vs durable mechanical circulatory support alone for patients with advanced heart failure[J]. JAMA Cardiol, 2020, 5(6): 652-659. DOI: 10.1001/jamacardio.2020.0631.
    [3]
    SUAREZ-PIERRE A, IGUIDBASHIAN J, STUART C, et al. Appraisal of donation after circulatory death: how far could we expand the heart donor pool?[J]. Ann Thorac Surg, 2022, 114(3): 676-682. DOI: 10.1016/j.athoracsur.2022.01.042.
    [4]
    BAKHTIYAR SS, GODFREY EL, AHMED S, et al. Survival on the heart transplant waiting list[J]. JAMA Cardiol, 2020, 5(11): 1227-1235. DOI: 10.1001/jamacardio.2020.2795.
    [5]
    KUMAR A, HOWARD A, THOMAS CP. Estimated glomerular filtration rate at transplant listing and other predictors of post-heart transplant mortality and the development of ESRD[J]. Transplantation, 2020, 104(11): 2444-2452. DOI: 10.1097/TP.0000000000003159.
    [6]
    BARUA S, YANG T, CONTE S, et al. Value of renal histology in predicting cardiorenal outcomes in heart transplant-listed patients[J]. Transplant Direct, 2022, 9(1): e1424. DOI: 10.1097/TXD.0000000000001424.
    [7]
    CHEN JW, CHOU NK, WANG CH, et al. Impact of pretransplant renal replacement therapy on clinical outcome after isolated heart transplantation[J]. Transpl Int, 2022, 35: 10185. DOI: 10.3389/ti.2022.10185.
    [8]
    KIM D, CHOI JO, CHO YH, et al. Impact of preoperative renal replacement therapy on the clinical outcome of heart transplant patients[J]. Sci Rep, 2021, 11(1): 13398. DOI: 10.1038/s41598-021-92800-0.
    [9]
    KUMAR A, BONNELL LN, THOMAS CP. Severely reduced kidney function assessed by a single eGFR determination at the time of an isolated heart transplant does not predict inevitable posttransplant ESKD[J]. Transplantation, 2023, 107(4): 981-987. DOI: 10.1097/TP.0000000000004350.
    [10]
    HONG KN, IRIBARNE A, WORKU B, et al. Who is the high-risk recipient? predicting mortality after heart transplant using pretransplant donor and recipient risk factors[J]. Ann Thorac Surg, 2011, 92(2): 520-527. DOI: 10.1016/j.athoracsur.2011.02.086.
    [11]
    KILIC A, WEISS ES, ARNAOUTAKIS GJ, et al. Identifying recipients at high risk for graft failure after heart retransplantation[J]. Ann Thorac Surg, 2012, 93(3): 712-716. DOI: 10.1016/j.athoracsur.2011.10.065.
    [12]
    LUND LH, EDWARDS LB, KUCHERYAVAYA AY, et al. The Registry of the International Society for Heart and Lung Transplantation: thirty-second official adult heart transplantation report--2015; focus theme: early graft failure[J]. J Heart Lung Transplant, 2015, 34(10): 1244-1254. DOI: 10.1016/j.healun.2015.08.003.
    [13]
    ROVIN BH, ADLER SG, BARRATT J, et al. Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases[J]. Kidney Int, 2021, 100(4): 753-779. DOI: 10.1016/j.kint.2021.05.015.
    [14]
    LEVEY AS, STEVENS LA. Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions[J]. Am J Kidney Dis, 2010, 55(4): 622-627. DOI: 10.1053/j.ajkd.2010.02.337.
    [15]
    SCICCHITANO P, IACOVIELLO M, PASSANTINO A, et al. The prognostic impact of estimated creatinine clearance by bioelectrical impedance analysis in heart failure: comparison of different eGFR formulas[J]. Biomedicines, 2021, 9(10): 1307. DOI: 10.3390/biomedicines9101307.
    [16]
    LISBOA PJG, JAYABALAN M, ORTEGA-MARTORELL S, et al. Enhanced survival prediction using explainable artificial intelligence in heart transplantation[J]. Sci Rep, 2022, 12(1): 19525. DOI: 10.1038/s41598-022-23817-2.
    [17]
    MEHRA MR, CANTER CE, HANNAN MM, et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update[J]. J Heart Lung Transplant, 2016, 35(1): 1-23. DOI: 10.1016/j.healun.2015.10.023.
    [18]
    SINGH TP, GIVERTZ MM, GAUVREAU K. Risk stratification for in-hospital mortality after heart transplantation using the modification of diet in renal disease and the chronic kidney disease epidemiology collaboration equations for estimated glomerular filtration rate[J]. Transplantation, 2014, 98(9): 1000-1006. DOI: 10.1097/TP.0000000000000151.
    [19]
    DECATO TW, HAVERKAMP H, HEGEWALD MJ. Cardiopulmonary exercise testing (CPET)[J]. Am J Respir Crit Care Med, 2020, 201(1): P1-P2. DOI: 10.1164/rccm.2011P1.
    [20]
    RIETH AJ, RICHTER MJ, TELLO K, et al. Exercise hemodynamics in heart failure patients with preserved and mid-range ejection fraction: key role of the right heart[J]. Clin Res Cardiol, 2022, 111(4): 393-405. DOI: 10.1007/s00392-021-01884-1.
    [21]
    CORRÀ U, AGOSTONI PG, ANKER SD, et al. Role of cardiopulmonary exercise testing in clinical stratification in heart failure. a position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology[J]. Eur J Heart Fail, 2018, 20(1): 3-15. DOI: 10.1002/ejhf.979.
    [22]
    BROCKLEBANK PW, KWON JH, HASHMI ZA, et al. The impact of changes in renal function during waitlist time on outcomes after heart transplantation[J]. J Card Surg, 2022, 37(3): 590-599. DOI: 10.1111/jocs.16188.
    [23]
    VIEIRA JL, MEHRA MR. Heart transplantation candidacy[J]. Curr Opin Organ Transplant, 2021, 26(1): 69-76. DOI: 10.1097/MOT.0000000000000828.
    [24]
    CLERKIN KJ, SALAKO O, FRIED JA, et al. Impact of temporary percutaneous mechanical circulatory support before transplantation in the 2018 heart allocation system[J]. JACC Heart Fail, 2022, 10(1): 12-23. DOI: 10.1016/j.jchf.2021.08.003.
    [25]
    KOBASHIGAWA J, DADHANIA DM, FARR M, et al. Consensus conference on heart-kidney transplantation[J]. Am J Transplant, 2021, 21(7): 2459-2467. DOI: 10.1111/ajt.16512.
    [26]
    DANI A, PRICE N, THANGAPPAN K, et al. Heart-kidney listing is better than isolated heart listing for pediatric heart transplant candidates with significant renal insufficiency[J]. J Thorac Cardiovasc Surg, 2022, 164(6): 2019-2031. DOI: 10.1016/j.jtcvs.2021.10.082.
    [27]
    ROSSI AP, VELLA JP. Acute kidney disease after liver and heart transplantation[J]. Transplantation, 2016, 100(3): 506-514. DOI: 10.1097/TP.0000000000000916.
    [28]
    GARCÍA-GIGORRO R, RENES-CARREÑO E, CORRES PEIRETTI MA, et al. Incidence, risk factors and outcomes of early acute kidney injury after heart transplantation: an 18-year experience[J]. Transplantation, 2018, 102(11): 1901-1908. DOI: 10.1097/TP.0000000000002293.
    [29]
    SHOJI S, KUNO T, KOHSAKA S, et al. Incidence and long-term outcome of heart transplantation patients who develop postoperative renal failure requiring dialysis[J]. J Heart Lung Transplant, 2022, 41(3): 356-364. DOI: 10.1016/j.healun.2021.11.017.
    [30]
    ROEST S, HESSELINK DA, KLIMCZAK-TOMANIAK D, et al. Incidence of end-stage renal disease after heart transplantation and effect of its treatment on survival[J]. ESC Heart Fail, 2020, 7(2): 533-541. DOI: 10.1002/ehf2.12585.
    [31]
    NICOARA A, KRETZER A, COOTER M, et al. Association between primary graft dysfunction and acute kidney injury after orthotopic heart transplantation - a retrospective, observational cohort study[J]. Transpl Int, 2020, 33(8): 887-894. DOI: 10.1111/tri.13615.
    [32]
    FORTRIE G, MANINTVELD OC, CALISKAN K, et al. Acute kidney injury as a complication of cardiac transplantation: incidence, risk factors, and impact on 1-year mortality and renal function[J]. Transplantation, 2016, 100(8): 1740-1749. DOI: 10.1097/TP.0000000000000956.
    [33]
    MCALISTER FA, EZEKOWITZ J, TARANTINI L, et al. Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formula[J]. Circ Heart Fail, 2012, 5(3): 309-314. DOI: 10.1161/CIRCHEARTFAILURE.111.966242.
    [34]
    OTAKI Y, WATANABE T, SHIMIZU M, et al. Association of malnutrition with renal dysfunction and clinical outcome in patients with heart failure[J]. Sci Rep, 2022, 12(1): 16673. DOI: 10.1038/s41598-022-20985-z.
    [35]
    ZHOU X, NAKAMURA K, SAHARA N, et al. Exploring and identifying prognostic phenotypes of patients with heart failure guided by explainable machine learning[J]. Life (Basel), 2022, 12(6): 776. DOI: 10.3390/life12060776.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(4)  / Tables(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (184) PDF downloads(33) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return